HOME Top Market Reports Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT (Technetium), PET (F-18)), Therapeutic (Beta Emitters (I-131), Alpha Emitters, Brachytherapy(Y-90))), Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2023

Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT (Technetium), PET (F-18)), Therapeutic (Beta Emitters (I-131), Alpha Emitters, Brachytherapy(Y-90))), Application (Oncology, Thyroid, Cardiology) - Global Forecasts to 2023

By: marketsandmarkets.com
Publishing Date: June 2018
Report Code: PH 3590

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


The global nuclear medicine market is expected to register a CAGR of 5.9% during the forecast period to reach USD 5.26 billion by 2023 from USD 3.69 billion in 2017. Base year considered for the report is 2017 and the forecast period is 2018–2023.

Objectives of the Study:

  • To define, describe, and forecast the global nuclear medicine market on the basis of type, application, procedural volume, and region
  • To provide detailed information about factors influencing market growth (drivers, restraints, opportunities, and industry-specific challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To forecast the size of market segments with respect to four regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW)
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To analyze the market structure, profile key players of the market, and comprehensively analyze their core competencies
  • To track and analyze competitive developments such as new product launches; partnerships, agreements, and collaborations; expansions; and acquisitions in the global nuclear medicine market

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global nuclear medicine market and estimate the size of other dependent submarkets. Various secondary sources such as the Organisation for Economic Co-operation and Development (OECD), European Association of Nuclear Medicine (EANM), National Institutes of Health (NIH), World Nuclear Association (WNA), International Atomic Energy Agency (IAEA), Nuclear Regulatory Commission (NRC), Society of Nuclear Medicine and Molecular Imaging (SNMMI), Nuclear Energy Agency (NEA), Australian Nuclear Science and Technology Organisation (ANSTO), directories, industry journals, databases, and annual reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

Nuclear Medicine/Radiopharmaceuticals Market

To know about the assumptions considered for the study, download the pdf brochure

The prominent players in the global nuclear medicine market are Cardinal Health (US), GE Healthcare (US), and Curium (France).

Target Audience:

  • Diagnostic laboratories
  • Hospitals
  • Venture capitalists
  • Business research and consulting service providers

Scope of the Report:

The research report categorizes the nuclear medicine market into the following segments and subsegments:

By Type

  • Diagnostics
    • SPECT Radiopharmaceuticals
      • Technetium-99m
      • Thallium-201
      • Gallium-67
      • Iodine-123
      • Other SPECT Isotopes (In-111 and Xe-133)
    • PET Radiopharmaceuticals
      • Fluorine-18
      • Rubidium-82
      • Other PET Isotopes (C-11, N-13, O-15, Cu-64, I-124, and Ga-68)
  • Therapeutics
    • Beta Emitters
      • Iodine-131
      • Samarium-153
      • Rhenium-186
      • Yttrium-90
      • Lutetium-177
      • Other Beta Emitters (Co-60, Ru-106, Au-198, and Cs-137)
    • Alpha Emitters
      • Iodine-131
    • Brachytherapy Isotopes  
      • Iodine-125
      • Palladium-103
      • Cesium-131
      • Iridium-192
      • Other Brachytherapy Isotopes (Cu-67, Yb-175, Sr-90, P-32, P-33, Ho-166, Re-188, and Sn-117m)

By Applications

  • Diagnostics
    • SPECT
      • Cardiology
      • Lymphoma
      • Neurology
      • Thyroid
      • Other SPECT Applications (prostate cancer diagnosis, bone scans, and white cell scans) 
    • PET Radiopharmaceuticals
      • Oncology
      • Cardiology
      • Neurology
      • Other PET Applications
  • Therapeutics
    • Thyroid
    • Bone Metastasis
    • Lymphoma
    • Endocrine Tumors
    • Other Therapeutic Applications

By Procedural Volume

  • Diagnostics Market
    • SPECT
    • PET
  • Therapeutics Market
    • Beta Emitters
    • Alpha Emitters
    • Brachytherapy Isotopes

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • APAC
  • Rest of the World

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (Up to 5

Table of Contents

1 Introduction (Page No. - 20)
    1.1 Objectives of Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 23)
    2.1 Research Methodology Steps
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
                    2.2.1.1 Key Data From Secondary Sources
           2.2.2 Primary Research
                    2.2.2.1 Key Insights From Primary Sources
    2.3 Market Size Estimation Methodology
    2.4 Market Data Validation and Triangulation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 31)

4 Premium Insights (Page No. - 34)
    4.1 Nuclear Medicine: Market Overview
    4.2 Geographic Analysis: Nuclear Medicine Market for Pet Applications, By Type (2017)
    4.3 Nuclear Medicine Market Share, By Type, 2018 vs 2023
    4.4 Geographical Snapshot of the Nuclear Medicine Market

5 Market Overview (Page No. - 38)
    5.1 Introduction
           5.1.2 Market Dynamics
           5.1.3 Drivers
                    5.1.3.1 Increasing Incidence and Prevalence of Target Conditions
                    5.1.3.2 Alpha Radioimmunotherapy-Based Targeted Cancer Treatment
                    5.1.3.3 Initiatives to Lessen the Demand-Supply Gap of Mo-99
           5.1.4 Restraints
                    5.1.4.1 Short Half-Life of Radiopharmaceuticals
           5.1.5 Opportunities
                    5.1.5.1 Use of Radiopharmaceuticals in Neurological Applications
           5.1.6 Challenges
                    5.1.6.1 Hospital Budget Cuts and High Equipment Prices

6 Nuclear Medicine/Radiopharmaceuticals Market, By Type (Page No. - 42)
    6.1 Introduction
    6.2 Diagnostic Nuclear Medicine
           6.2.1 Spect Radiopharmaceuticals
                    6.2.1.1 Tc-99m
                    6.2.1.2 Tl-201
                    6.2.1.3 Ga-67
                    6.2.1.4 I-123
                    6.2.1.5 Other Spect Isotopes
           6.2.2 Pet Radiopharmaceuticals
                    6.2.2.1 F-18
                    6.2.2.2 Ru-82
                    6.2.2.3 Other Pet Isotopes
    6.3 Therapeutic Nuclear Medicine
           6.3.1 Alpha Emitters
                    6.3.1.1 Ra-223
           6.3.2 Beta Emitters
                    6.3.2.1 I-131
                    6.3.2.2 Y-90
                    6.3.2.3 Sm-153
                    6.3.2.4 Re-186
                    6.3.2.5 Lu-177
                    6.3.2.6 Other Beta Emitters
           6.3.3 Brachytherapy Isotopes
                    6.3.3.1 I-125
                    6.3.3.2 Ir-192
                    6.3.3.3 Pd-103
                    6.3.3.4 Cs-131
                    6.3.3.5 Other Brachytherapy Isotopes

7 Nuclear Medicine/Radiopharmaceuticals Market, By Application (Page No. - 87)
    7.1 Introduction
    7.2 Diagnostic Applications
           7.2.1 Spect Applications
                    7.2.1.1 Cardiology
                    7.2.1.2 Lymphoma
                    7.2.1.3 Neurology
                    7.2.1.4 Thyroid
                    7.2.1.5 Other Spect Applications
           7.2.2 Pet Applications
                    7.2.2.1 Oncology
                    7.2.2.2 Cardiology
                    7.2.2.3 Neurology
                    7.2.2.4 Other Pet Applications
    7.3 Therapeutic Applications
           7.3.1 Thyroid
           7.3.2 Bone Metastasis
           7.3.3 Lymphoma
           7.3.4 Endocrine Tumors
           7.3.5 Other Therapeutic Applications

8 Nuclear Medicine/Radiopharmaceuticals Market, By Procedural Volume (Page No. - 103)
    8.1 Introduction
    8.2 Diagnostic Procedures
           8.2.1 Spect Radiopharmaceuticals
           8.2.2 Pet Radiopharmaceuticals
    8.3 Therapeutic Procedures
           8.3.1 Beta Emitters
           8.3.2 Alpha Emitters
           8.3.3 Brachytherapy Isotopes

9 Nuclear Medicine/Radiopharmaceuticals Market, By Region (Page No. - 112)
    9.1 Introduction
    9.2 North America
           9.2.1 US
           9.2.2 Canada
    9.3 Europe
           9.3.1 Germany
           9.3.2 France
           9.3.3 UK
           9.3.4 Italy
           9.3.5 Spain
           9.3.6 RoE
    9.4 Asia Pacific
    9.5 Rest of the World

10 Competitive Landscape (Page No. - 173)
     10.1 Overview
     10.2 Market Share Analysis
     10.3 Competitive Scenario
             10.3.1 Agreements, Partnerships, and Contracts
             10.3.2 Product Approvals
             10.3.3 Funding
             10.3.4 Acquisitions
             10.3.5 Expansions
             10.3.6 Other Developments

11 Company Profiles (Page No. - 180)
(Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View)*
     11.1 Cardinal Health
     11.2 Ge Healthcare (A Fully-Owned Subsidiary of General Electric Company)
     11.3 Curium
     11.4 Lantheus Medical Imaging
     11.5 Bayer
     11.6 Bracco Imaging
     11.7 Eczacibasi-Monrol Nuclear Products
     11.8 Nordion (A Subsidiary of Sterigenics International)
     11.9 Advanced Accelerator Applications (Aaa, Acquired By Novartis)

*Business Overview, Products Offered, Recent Developments, SWOT Analysis, MnM View Might Not Be Captured in Case of Unlisted Companies.

12 Appendix (Page No. - 203)
     12.1 Discussion Guide
     12.2 Introducing RT: Real-Time Market Intelligence
     12.3 Available Customizations
     12.4 Related Reports
     12.5 Author Details


List of Tables (250 Tables)

Table 1 New Reactors Expected to Open During the Forecast Period
Table 2 Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 3 Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 4 Diagnostic Nuclear Medicine Market, By Region, 2016–2023 (USD Million)
Table 5 North America: Diagnostic Nuclear Medicine Market, By Country, 2016–2023 (USD Million)
Table 6 Europe: Diagnostic Nuclear Medicine Market, By Country, 2016–2023 (USD Million)
Table 7 Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 8 Spect Radiopharmaceuticals Market, By Region, 2016–2023 (USD Million)
Table 9 North America: Spect Radiopharmaceuticals Market, By Country, 2016–2023 (USD Million)
Table 10 Europe: Spect Radiopharmaceuticals Market, By Country, 2016–2023 (USD Million)
Table 11 Tc-99m Market, By Region, 2016–2023 (USD Million)
Table 12 North America: Tc-99m Market, By Country, 2016–2023 (USD Million)
Table 13 Europe: Tc-99m Market, By Country, 2016–2023 (USD Million)
Table 14 Tl-201 Market, By Region, 2016–2023 (USD Million)
Table 15 North America: Tl-201 Market, By Country, 2016–2023 (USD Million)
Table 16 Europe: Tl-201 Market, By Country, 2016–2023 (USD Million)
Table 17 Ga-67 Market, By Region, 2016–2023 (USD Million)
Table 18 North America: Ga-67 Market, By Country, 2016–2023 (USD Million)
Table 19 Europe: Ga-67 Market, By Country, 2016–2023 (USD Million)
Table 20 I-123 Market, By Region, 2016–2023 (USD Million)
Table 21 North America: I-123 Market, By Country, 2016–2023 (USD Million)
Table 22 Europe: I-123 Market, By Country, 2016–2023 (USD Million)
Table 23 Other Spect Isotopes Market, By Region, 2016–2023 (USD Million)
Table 24 North America: Other Spect Isotopes Market, By Country, 2016–2023 (USD Million)
Table 25 Europe: Other Spect Isotopes Market, By Country, 2016–2023 (USD Million)
Table 26 Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 27 Pet Radiopharmaceuticals Market, By Region, 2016–2023 (USD Million)
Table 28 North America: Pet Radiopharmaceuticals Market, By Country, 2016–2023 (USD Million)
Table 29 Europe: Pet Radiopharmaceuticals Market, By Country, 2016–2023 (USD Million)
Table 30 F-18 Market, By Region, 2016–2023 (USD Million)
Table 31 North America: F-18 Market, By Country, 2016–2023 (USD Million)
Table 32 Europe: F-18 Market, By Country, 2016–2023 (USD Million)
Table 33 Ru-82 Market, By Region, 2016–2023 (USD Million)
Table 34 North America: Ru-82 Market, By Country, 2016–2023 (USD Million)
Table 35 Europe: Ru-82 Market, By Country, 2016–2023 (USD Million)
Table 36 Other Pet Isotopes Market, By Region, 2016–2023 (USD Million)
Table 37 North America: Other Pet Isotopes Market, By Country, 2016–2023 (USD Million)
Table 38 Europe: Other Pet Isotopes Market, By Country, 2016–2023 (USD Million)
Table 39 Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 40 Therapeutic Nuclear Medicine Market, By Region, 2016–2023 (USD Million)
Table 41 North America: Therapeutic Nuclear Medicine Market, By Country, 2016–2023 (USD Million)
Table 42 Europe: Therapeutic Nuclear Medicine Market, By Country, 2016–2023 (USD Million)
Table 43 Ra-223 Market, By Region, 2016–2023 (USD Million)
Table 44 North America: Ra-223 Market, By Country, 2016–2023 (USD Million)
Table 45 Europe: Ra-223 Market, By Country, 2016–2023 (USD Million)
Table 46 Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 47 Beta Emitters Market, By Region, 2016–2023 (USD Million)
Table 48 North America: Beta Emitters Market, By Country, 2016–2023 (USD Million)
Table 49 Europe: Beta Emitters Market, By Country, 2016–2023 (USD Million)
Table 50 I-131 Market, By Region, 2016–2023 (USD Million)
Table 51 North America: I-131 Market, By Country, 2016–2023 (USD Million)
Table 52 Europe: I-131 Market, By Country, 2016–2023 (USD Million)
Table 53 Y-90 Market, By Region, 2016–2023 (USD Million)
Table 54 North America: Y-90 Market, By Country, 2016–2023 (USD Million)
Table 55 Europe: Y-90 Market, By Country, 2016–2023 (USD Million)
Table 56 Sm-153 Market, By Region, 2016–2023 (USD Million)
Table 57 North America: Sm-153 Market, By Country, 2016–2023 (USD Million)
Table 58 Europe: Sm-153 Market, By Country, 2016–2023 (USD Million)
Table 59 Re-186 Market, By Region, 2016–2023 (USD Million)
Table 60 North America: Re-186 Market, By Country, 2016–2023 (USD Million)
Table 61 Europe: Re-186 Market, By Country, 2016–2023 (USD Million)
Table 62 Lu-177 Market, By Region, 2016–2023 (USD Million)
Table 63 North America: Lu-177 Market, By Country, 2016–2023 (USD Million)
Table 64 Europe: Lu-177 Market, By Country, 2016–2023 (USD Million)
Table 65 Other Beta Emitters Market, By Region, 2016–2023 (USD Million)
Table 66 North America: Other Beta Emitters Market, By Country, 2016–2023 (USD Million)
Table 67 Europe: Other Beta Emitters Market, By Country, 2016–2023 (USD Million)
Table 68 Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 69 Brachytherapy Isotopes Market, By Region, 2016–2023 (USD Million)
Table 70 North America: Brachytherapy Isotopes Market, By Country, 2016–2023 (USD Million)
Table 71 Europe: Brachytherapy Isotopes Market, By Country, 2016–2023 (USD Million)
Table 72 I-125 Market, By Region, 2016–2023 (USD Million)
Table 73 North America: Iodine-125 Market, By Country, 2016–2023 (USD Million)
Table 74 Europe: Iodine-125 Market, By Country, 2016–2023 (USD Million)
Table 75 Ir-192 Market, By Region, 2016–2023 (USD Million)
Table 76 North America: Ir-192 Market, By Country, 2016–2023 (USD Million)
Table 77 Europe: Ir-192 Market, By Country, 2016–2023 (USD Million)
Table 78 Pd-103 Market, By Region, 2016–2023 (USD Million)
Table 79 North America: Pd-103 Market, By Country, 2016–2023 (USD Million)
Table 80 Europe: Pd-103 Market, By Country, 2016–2023 (USD Million)
Table 81 Cs-131 Market, By Region, 2016–2023 (USD Million)
Table 82 North America: Cs-131 Market, By Country, 2016–2023 (USD Million)
Table 83 Europe: Cs-131 Market, By Country, 2016–2023 (USD Million)
Table 84 Other Brachytherapy Isotopes Market, By Region, 2016–2023 (USD Million)
Table 85 North America: Other Brachytherapy Isotopes Market, By Country, 2016–2023 (USD Million)
Table 86 Europe: Other Brachytherapy Isotopes Market, By Country, 2016–2023 (USD Million)
Table 87 Spect Applications Market, By Type, 2016–2023 (USD Million)
Table 88 Spect Applications Market, By Region, 2016–2023 (USD Million)
Table 89 Cardiology Applications Market, By Region, 2016–2023 (USD Million)
Table 90 Lymphoma Applications Market, By Region, 2016–2023 (USD Million)
Table 91 Neurology Applications Market, By Region, 2016–2023 (USD Million)
Table 92 Thyroid Applications Market, By Region, 2016–2023 (USD Million)
Table 93 Other Spect Applications Market, By Region, 2016–2023 (USD Million)
Table 94 Pet Applications Market, By Type, 2016–2023 (USD Million)
Table 95 Pet Applications Market, By Region, 2016–2023 (USD Million)
Table 96 Oncology Applications Market, By Region, 2016–2023 (USD Million)
Table 97 Cardiology Applications Market, By Region, 2016–2023 (USD Million)
Table 98 Neurology Applications Market, By Region, 2016–2023 (USD Million)
Table 99 Other Pet Applications Market, By Region, 2016–2023 (USD Million)
Table 100 Therapeutic Applications Market, By Type, 2016–2023 (USD Million)
Table 101 Therapeutic Applications Market, By Region, 2016–2023 (USD Million)
Table 102 Thyroid Applications Market, By Region, 2016–2023 (USD Million)
Table 103 Bone Metastasis Applications Market, By Region, 2016–2023 (USD Million)
Table 104 Lymphoma Applications Market, By Region, 2016–2023 (USD Million)
Table 105 Endocrine Applications Market, By Region, 2016–2023 (USD Million)
Table 106 Other Therapeutic Applications Market, By Region, 2016–2023 (USD Million)
Table 107 Nuclear Medicine Procedures Market, By Type, 2016–2023 (Thousand Procedures)
Table 108 Nuclear Medicine Procedures Market, By Region, 2016–2023 (Thousand Procedures)
Table 109 Diagnostic Procedures Market, By Type, 2016–2023 (Thousand Procedures)
Table 110 Diagnostic Procedures Market, By Region, 2016–2023 (Thousand Procedures)
Table 111 Spect Radiopharmaceuticals Market, By Type, 2016–2023 (Thousand Procedures)
Table 112 Spect Radiopharmaceuticals Market, By Type, By Region, 2016–2023 (Thousand Procedures)
Table 113 Pet Radiopharmaceuticals Market, By Type, 2016–2023 (Thousand Procedures)
Table 114 Pet Radiopharmaceuticals Market, By Type, 2016–2023 (Thousand Procedures)
Table 115 Therapeutic Procedures Market, By Type, 2016–2023 (Thousand Procedures)
Table 116 Therapeutic Procedures Market, By Region, 2016–2023 (Thousand Procedures)
Table 117 Beta Emitters Market, By Type, 2016–2023 (Thousand Procedures)
Table 118 Beta Emitters Market, By Region, 2016–2023 (Thousand Procedures)
Table 119 Alpha Emitters Market, By Region, 2016–2023 (Thousand Procedures)
Table 120 Brachytherapy Isotopes Market, By Type, 2016–2023 (Thousand Procedures)
Table 121 Brachytherapy Isotopes Market, By Region, 2016–2023 (Thousand Procedures)
Table 122 Nuclear Medicine Market, By Region, 2016–2023 (USD Million)
Table 123 North America: Nuclear Medicine Market, By Country, 2016–2023 (USD Million)
Table 124 North America: Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 125 North America: Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 126 North America: Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 127 North America: Spect Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 128 North America: Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 129 North America: Pet Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 130 North America: Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 131 North America: Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 132 North America: Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 133 North America: Therapeutic Nuclear Medicine Market, By Application, 2016–2023 (USD Million)
Table 134 US: Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 135 US: Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 136 US: Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 137 US: Spect Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 138 US: Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 139 US: Pet Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 140 US: Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 141 US: Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 142 US: Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 143 US: Therapeutic Nuclear Medicine Market, By Application, 2016–2023 (USD Million)
Table 144 Canada: Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 145 Canada: Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 146 Canada: Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 147 Canada: Spect Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 148 Canada: Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 149 Canada: Pet Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 150 Canada: Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 151 Canada: Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 152 Canada: Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 153 Canada: Therapeutic Nuclear Medicine Market, By Application, 2016–2023 (USD Million)
Table 154 Europe: Nuclear Medicine Market, By Country, 2016–2023 (USD Million)
Table 155 Europe: Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 156 Europe: Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 157 Europe: Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 158 Europe: Spect Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 159 Europe: Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 160 Europe: Pet Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 161 Europe: Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 162 Europe: Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 163 Europe: Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 164 Europe: Therapeutic Nuclear Medicine Market, By Application, 2016–2023 (USD Million)
Table 165 Germany: Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 166 Germany: Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 167 Germany: Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 168 Germany: Spect Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 169 Germany: Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 170 Germany: Pet Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 171 Germany: Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 172 Germany: Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 173 Germany: Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 174 Germany: Therapeutic Nuclear Medicine Market, By Application, 2016–2023 (USD Million)
Table 175 France: Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 176 France: Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 177 France: Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 178 France: Spect Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 179 France: Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 180 France: Pet Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 181 France: Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 182 France: Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 183 France: Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 184 France: Therapeutic Nuclear Medicine Market, By Application, 2016–2023 (USD Million)
Table 185 UK: Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 186 UK: Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 187 UK: Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 188 UK: Spect Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 189 UK: Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 190 UK: Pet Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 191 UK: Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 192 UK: Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 193 UK: Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 194 UK: Therapeutic Nuclear Medicine Market, By Application, 2016–2023 (USD Million)
Table 195 Italy: Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 196 Italy: Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 197 Italy: Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 198 Italy: Spect Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 199 Italy: Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 200 Italy: Pet Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 201 Italy: Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 202 Italy: Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 203 Italy: Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 204 Italy: Therapeutic Nuclear Medicine Market, By Application, 2016–2023 (USD Million)
Table 205 Spain: Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 206 Spain: Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 207 Spain: Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 208 Spain: Spect Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 209 Spain: Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 210 Spain: Pet Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 211 Spain: Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 212 Spain: Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 213 Spain: Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 214 Spain: Therapeutic Nuclear Medicine Market, By Application, 2016–2023 (USD Million)
Table 215 RoE: Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 216 RoE: Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 217 RoE: Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 218 RoE: Spect Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 219 RoE: Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 220 RoE: Pet Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 221 RoE: Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 222 RoE: Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 223 RoE: Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 224 RoE: Therapeutic Nuclear Medicine Market, By Application, 2016–2023 (USD Million)
Table 225 Asia Pacific: Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 226 Asia Pacific: Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 227 Asia Pacific: Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 228 Asia Pacific: Spect Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 229 Asia Pacific: Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 230 Asia Pacific: Pet Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 231 Asia Pacific: Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 232 Asia Pacific: Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 233 Asia Pacific: Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 234 Asia Pacific: Therapeutic Nuclear Medicine Market, By Application, 2016–2023 (USD Million)
Table 235 RoW: Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 236 RoW: Diagnostic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 237 RoW: Spect Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 238 RoW: Spect Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 239 RoW: Pet Radiopharmaceuticals Market, By Type, 2016–2023 (USD Million)
Table 240 RoW: Pet Radiopharmaceuticals Market, By Application, 2016–2023 (USD Million)
Table 241 RoW: Therapeutic Nuclear Medicine Market, By Type, 2016–2023 (USD Million)
Table 242 RoW: Beta Emitters Market, By Type, 2016–2023 (USD Million)
Table 243 RoW: Brachytherapy Isotopes Market, By Type, 2016–2023 (USD Million)
Table 244 RoW: Therapeutic Nuclear Medicine Market, By Application, 2016–2023 (USD Million)
Table 245 Agreements, Partnerships, and Contracts (2015–2018)
Table 246 Product Approvals (2015–2018)
Table 247 Funding (2015–2018)
Table 248 Acquisitions (2015–2018)
Table 249 Expansions (2015–2018)
Table 250 Other Developments (2015–2018)


List of Figures (34 Figures)

Figure 1 Global Nuclear Medicine Market: Research Methodology
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Bottom-Up Approach
Figure 4 Top-Down Approach
Figure 5 Research Design
Figure 6 Data Triangulation Methodology
Figure 7 Nuclear Medicine Market, By Type, 2018 vs 2023 (USD Million)
Figure 8 Nuclear Medicine Market for Spect Applications, By Type, 2018 vs 2023 (USD Million)
Figure 9 Nuclear Medicine Market for Pet Applications, By Type, 2018 vs 2023 (USD Million)
Figure 10 Rising Incidence & Prevalence of Cancer & Cardiovascular Diseases—Key Factor Supporting Market Growth During the Forecast Period
Figure 11 Oncology Segment Dominated the Nuclear Medicine Market for Pet Applications in 2017
Figure 12 Diagnostics Segment Will Continue to Dominate the Nuclear Medicine Market in 2023
Figure 13 Asia Pacific to Witness the Highest Growth in the Nuclear Medicine Market During the Forecast Period
Figure 14 Drivers, Restraints, Opportunities, and Challenges
Figure 15 Diagnostic Nuclear Medicine Segment Commanded the Largest Share of the Nuclear Medicine Market in 2017
Figure 16 Pet Radiopharmaceuticals to Register the Highest Growth Rate During the Forecast Period
Figure 17 Alpha Emitters Will Continue to Dominate the Therapeutic Nuclear Medicine Market During the Forecast Period
Figure 18 Geographical Snapshot of the Nuclear Medicine Market
Figure 19 Thyroid Segment is Expected to Register the Highest CAGR in the Spect Applications Market During the Forecast Period
Figure 20 Oncology Applications Segment is Expected to Grow at the Highest CAGR in the Pet Applications Market During the Forecast Period
Figure 21 Endocrine Tumors Application Segment is Expected to Register the Highest CAGR in the Therapeutic Applications Market During the Forecast Period
Figure 22 Nuclear Medicine Procedures Market, By Type, 2018 vs 2023 (Thousand Procedures)
Figure 23 North America to Dominate the Nuclear Medicine Market in 2018
Figure 24 North America: Nuclear Medicine Market Snapshot
Figure 25 Europe: Nuclear Medicine Market Snapshot
Figure 26 Asia Pacific: Nuclear Medicine Market Snapshot
Figure 27 RoW: Nuclear Medicine Market Snapshot
Figure 28 Key Developments in the Nuclear Medicine Market, 2015–2018
Figure 29 Market Share Analysis, By Key Players, 2017
Figure 30 Cardinal Health: Company Snapshot (2017)
Figure 31 GE Healthcare: Company Snapshot (2017)
Figure 32 Lantheus Medical Imaging: Company Snapshot (2017)
Figure 33 Bayer: Company Snapshot (2017)
Figure 34 Advanced Accelerator Applications: Company Snapshot (2016)

The nuclear medicine market is projected to reach USD 5.26 billion by 2023 from an estimated USD 3.95 billion in 2018 at a CAGR of 5.9%. The major influencing factors driving the growth of this market are the increasing incidence and prevalence of target conditions and initiatives to lessen the demand-supply gap of Mo-99.

By type, the global nuclear medicine market is segmented diagnostic and therapeutic nuclear medicine. The diagnostic segment is further segmented into SPECT and PET radiopharmaceuticals. The SPECT radiopharmaceuticals include Tc-99m, Tl-201, Ga-67, I-123, and others. The PET radiopharmaceuticals include F-18, Ru-82, and others. The therapeutic segment is further segmented into beta emitters, alpha emitters, and brachytherapy. The diagnostic segment accounted for the largest share of the nuclear medicine market, primarily due to the use of the diagnostic radiopharmaceutical Tc-99m which is used in a majority of nuclear medicine procedures.

Based on applications, the nuclear medicine market is segmented into diagnostic and therapeutic applications. The diagnostic applications are further segmented into SPECT applications and PET applications. Whereas the therapeutic applications are further segmented into thyroid, bone metastasis, lymphoma, endocrine tumors, and others (breast cancer, cervical cancer, GI tumors, and renal tumors). The SPECT application segment accounted for the largest share of the diagnostic nuclear medicine market by applications owing to the rising demand for cardiac imaging.

Based on procedural volume, the nuclear medicine market is segmented into volumes for diagnostic and therapeutic procedures. The diagnostic procedures market is segmented into procedural volumes of SPECT and PET radiopharmaceuticals. The therapeutic procedures market is segmented into procedural volumes beta emitters, alpha emitters, and brachytherapy isotopes. Tc-99m accounted for the largest number of procedures performed in the nuclear medicine market as it has a longer half-life and is easy to transport as compared to other radiopharmaceuticals.

Nuclear Medicine/Radiopharmaceuticals Market

By region, the global market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific market is expected to grow at the highest CAGR during the forecast period. This high growth can be attributed to the research initiatives in Japan, rising installations of PET scanners in India and China owing to technological advancement, and initiatives taken by the Australian government.

Factors such as short half-life of radiopharmaceuticals, hospital budget cuts, and high equipment prices are expected to limit the growth of the market to a certain extent.

The major market players in the nuclear medicine market include Cardinal Health (US), GE Healthcare (US), and Curium (France). Other players involved in this market are Bayer (Germany), Lantheus Medical Imaging (US), Advanced Accelerator Applications (France), and Jubilant Life Sciences (India). Other players in the nuclear medicine market include Bayer (Germany), Lantheus Medical Imaging (US), Advanced Accelerator Applications (France), and Jubilant Life Sciences (India).

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit https://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Pharmaceuticals Markets on KnowledgeStore
Request Demo